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present. It is quite possible that these sMSCs are extremely sensitive to
changes/damage to the joint environment and therefore may be exploited
as a sentinel for early detection of OA.
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NORMAL AND OSTEOARTHRITIC SYNOVIAL STEM CELL-DERIVED
TISSUE-ENGINEERED CONSTRUCTS RESPOND TO MECHANICAL
STIMULUS FOLLOWING CHONDROGENIC DIFFERENTIATION
G. Buckley-Herd1, R. Krawetz2, D.A. Hart2. 1BioMed. Engineering, Univ. of
Calgary, Calgary, AB, Canada; 2Dept. of Surgery, Univ. of Calgary, Calgary,
AB, Canada
Purpose: Tissue-engineering (TE) comprises cells, a scaffold, and
appropriate signals. In the context of TE of articular cartilage for
treatment of osteoarthritis (OA), synovial tissue-derived mesenchymal
stem cells (sMSCs) have been demonstrated to be particularly suitable.
These MSCs are present in the synovial ﬂuid and their numbers
increase dramatically with the onset of OA. Recently scaffold-free
tissue-engineered constructs (TECs) from sMSC monolayers treated
with ascorbic acid (AA) were developed in our laboratory. These TECs
retained their chondrogenic potential after transplantation into chondral
defects within a porcine model. However, the implanted TECs exhibited
suboptimal healing as they failed to take on a completely hyaline
phenotype based on the presence of ﬁbrous tissue at the surface of the
repair sites. Therefore, the objective of this study is to modify the present
TEC technology through the induction of chondrogenic differentiation
using biochemical and mechanical signals.
Methods: Human sMSCs were derived from donor synovial tissue and
synovial ﬂuid and isolated using magnetic puriﬁcation. When the cells
reached conﬂuence they were treated with either chondrogenic media
containing TGF-b3, BMP-2, AA, and dexamethasone, media supplemented
with only AA (TEC), or control media, for a period of 14 days. The
chondrogenic TECs (cTECs) and AA-treated TECs were then subjected to
mechanical compression for 24 hours with a loading protocol of 1 MPa
at 1Hz for 1 minute and 14 minutes of no load using a Flexcell system.
Non-loaded TECs were maintained in parallel as controls. After loading,
the remaining TECs and cultures were harvested for analysis. Analysis
included RT-qPCR, histology & immunohistochemistry, and mechanical
testing.
Results: Mechanical loading differentially regulated several genes
commonly used as markers of chondrogenic differentiation in both the
cTECs and AA-treated TECs (Fig. 1). Following mechanical compression,
mRNA expression of SOX-9 and aggrecan are upregulated, while type-II
collagen expression is highly variable. As well, histological assessment
indicated signiﬁcant differences in composition between the cTECs and
AA-treated TECs (Fig. 2). The cTECs appear to have increased collagen
content and are more sparsely populated with cells. Similar observations
were made for TECs formed using MSCs from OA tissue, however the OA
TECs tended to be quite variable in terms of their various properties.
Conclusions: The results indicate that the modiﬁed TEC protocol is
more effective than the original protocol for producing TECs that exhibit
characteristics similar to that of native articular cartilage, such as
increased collagen content and relatively low cell density. Optimization of
the protocol (e.g. loading regimen, timing of biochemical and mechanical
cues, etc.) could lead to further improved TEC properties. However,
additional modiﬁcations are necessary to achieve similar results with
OA TECs.
Fig. 1. Relative mRNA expression of chondrogenic markers in loaded
and unloaded cultures treated with either chondrogenic media (left) or
media containing AA (right), compared to initial controls.
Fig. 2. Sections of cTECs (A,B) and AA-treated TECs (C,D) stained
with Masson’s trichrome (blue: collagen; red/purple: cytoplasm; black:
nuclei). TECs were either loaded (A,C) or unloaded (B,D).
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B. Rocha, P. Ferna´ndez-Puente, J. Mateos, V. Calamia, L. Lourido,
C. Ferna´ndez-Costa, C. Ruiz-Romero, F.J. Blanco. Osteoarticular and
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Purpose: Mesenchymal stem cells (MSCs) are an attractive cell source
for cell therapy in osteoarthritis (OA) disease due to their capacity
to differentiate towards chondrocytes and their skill to mobility and
migration to the site of injury. To obtain more information about this
disease, we have analyzed the protein expression proﬁle of bone marrow
MSCs of OA patients under chondrogenic differentiation using the SILAC
(Isotope Labeling by Amino Acids in Cell Culture) technique.
Methods: Bone marrow cells were isolated from 3 OA patients and
cultured in an expansion medium deﬁcient in arginine and lysine.
Regular L-lys (Lys0) and L-arg (Arg0) were added to the cell population
harvested on day 2, whereas isotope-labeled L-lys (Lys6) and L-arg
(Arg10) forms were put in the cell population harvested on day 14
of differentiation. After complete incorporation of the heavy amino
acids, chondrogenic differentiation was induced by micromass culture
under a commercial medium for 14 days. Expression of cartilage speciﬁc
genes and histological assays were used to explore the chondrogenicity
of MSCs. Proteins extracted from the two different time points were
mixed 1:1 according to the measured protein concentrations, separated
in 10% polyacrylamide gels and visualized using colloidal blue. Whole gel
lines were cut into slices and subjected to in-gel digestion with trypsin.
Separation of the resulting tryptic peptides was performed by nanoscale
liquid chromatography coupled to mass spectrometry (nanoLC-MS/MS).
The identiﬁcation and quantiﬁcation of proteins were carried out with
Protein Pilot 2.0 software.
Results: Differentiation of MSCs was conﬁrmed by inmunohistochemical
detection of collagen II at day 14. Also, cells on day 2 and 14 show
a progressive increase in orange staining for proteoglycans. Using
metabolic labeling, we compared the proteomes at two different time
points of their chondrogenic differentiation. We have identiﬁed and
quantitatively analyzed 378 intracellular proteins. At least 46 of them
appeared signiﬁcantly regulated, including several glycolytic enzymes
and structural proteins. This indicates that signiﬁcant morphological
and biological changes occurred during the 14 days of differentiation.
33 proteins were increased in the differentiated state compared to
undifferentiated cells. Among them, we found a cartilage-speciﬁc protein,
perlecan, which is important in the developmental processes that occur
during chondrogenesis. In fact, it is able to inﬂuence extracellular
matrix by stimulating collagen ﬁbril formation.13 proteins exhibited a
signiﬁcantly reduced abundance from day 14 to day 2. Among them,
we found Tropomyosin 4, a predominant regulator in actin ﬁlament
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dynamics, which need to be regulated in proliferation, apoptosis and
differentiation. This suggests an important role of this protein in
chondrogenesis.
Conclusions: This study was focused on characterizing the speciﬁc
modulations in the proteome of bone marrow MSCs from OA patients
undergoing chondrogenic differentiation, using the SILAC method. The
comparison of these results with the correspondent proteomic proﬁle
of MSCs from healthy donors should be the objective of future studies.
Our proteomic approach based on metabolic labeling and the functional
analyses of those differential proteins will help us to explore the
underlying mechanisms involved in OA disease.
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MESENCHYMAL STEM CELLS EXERT PARACRINE EFFECTS ON
OSTEOARTHRITIC CARTILAGE AND SYNOVIUM
G.M. van Buul, E. Villafuertes, J.H. Waarsing, P.K. Bos, N. Kops,
J.A. Verhaar, H. Weinans, M.R. Bernsen, G.J. van Osch. Erasmus MC,
Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) is characterized by an imbalance of anabolic
and catabolic processes in synovial joints, resulting in progressive
cartilage damage. Mesenchymal stem cells (MSCs) have recently been
discovered to have immunomodulatory capacities by secreting anti-
inﬂammatory cytokines and growth factors. MSCs are promising
candidates for OA therapies and multiple animal studies show beneﬁcial
effects of MSCs on cartilage histology in various OA models. Interestingly,
applied cells do not seem to actively participate in formation of new
cartilage and mainly home to the synovium. We studied the paracrine
effects of MSCs on OA cartilage and synovium explants in vitro.
Methods: To stimulate primary human MSCs to secrete immunomod-
ulatory factors, they were cultured under inﬂammatory conditions in
medium containing 10% FCS with additional 50ng/ml TNFa and 50ng/ml
IFNg. After 24 hours medium was collected and designated “MSC
conditioned medium”. Human cartilage and synovium explants, obtained
during total knee replacement surgery, were cultured for 48 hours in
conditioned medium or in unconditioned control media with or without
TNFa and IFNg. MSCs and explants were studied for expression of genes
regulating inﬂammation (TNFa, TGFb, IL-6, IDO, IL-1b, IL-1RA, SOCS1
and SOCS3) and extracellular matrix degradation (TIMP2, ADAMTS-4,
ADAMTS5, MMP-1 and MMP-13). IL-6 and TIMP2 were measured in
MSC conditioned medium by means of ELISA’s. Statistical analysis was
performed using a mixed model ANOVA, in which treatment was
considered a ﬁxed factor and donor a random factor. A p-value <0.05
was considered statistically signiﬁcant.
Fig. 1. Effects of factors secreted by MSCs on OA cartilage. Gene expression
data are normalized to best keeper index (BKI, based on GAPDH, UBC and
HPRT) and relative to control without MSC secreted factors. * indicates
P < 0.05.
Results: MSCs: IFNg and TNFa resulted overall in an anti-inﬂammatory
phenotype. Speciﬁcally, it induced down-regulation of gene expression of
TNFa, TGFb, and TIMP2, while IL-6 and IDO were markedly upregulated
(P < 0.001 for all genes). IL-1b and TIMP1 were unaltered by the priming
procedure. IL-6 production by MSCs was upregulated upon cytokine
stimulation (2.6±3.0 ng/ml vs 40.2±15.0 ng/ml; P< 0.001) whereas TIMP2
production was not affected (25.2±6.8 ng/ml vs 23.5±7.7 ng/ml).
Cartilage (Fig. 1): IFNg and TNFa increased SOCS1 gene expression
(P = 0.029) and caused a trend towards upregulating ADAMTS-4
(P = 0.056) and ADAMTS-5 (P = 0.077) in cartilage explants. MMP-13
and IL-1RA were unaffected. MSC conditioned medium decreased
ADAMTS-5 (P < 0.001) and further upregulated IL-1RA (P =0.046). SOCS3
was downregulated (P = 0.044), whereas ADAMTS-4, MMP-13 and SOCS1
remained unchanged.
Synovium (Fig. 2): IFNg and TNFa upregulated MMP-1, TNFa, IL-1b, IL-1RA
and SOCS1 in synovium (P < 0.03 for all genes). MSC conditioned medium
downregulated the cytokine-induced expression of MMP-1 IL-1b and
further upregulated SOCS1. MMP-13 gene expression was not affected
by IFNg and TNFa stimulation or conditioned medium.
Fig. 2. Effects of factors secreted by MSCs on OA synovium. Gene
expression data are normalized to best keeper index (BKI, based on
GAPDH, UBC and HPRT) and relative to control without MSC secreted
factors. * indicates P < 0.05.
Conclusions: Conditioned medium containing factors secreted by MSCs
caused anti-catabolic and multiple anti-inﬂammatory responses in
cartilage and synovium explants. This indicates that MSCs have beneﬁcial
paracrine effects on the metabolism of osteoarthritic cartilage and
synovium. These results offer a possible working mechanism for MSCs
to modulate the osteoarthritis process, and encourage further use and
study of MSCs as a treatment for OA.
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DIRECT HUMAN CARTILAGE REPAIR USING THERMAL INKJET
PRINTING TECHNOLOGY
X. Cui1, K. Breitenkamp1, M. Finn1, M. Lotz1, C. Colwell2, D. D’Lima1,2.
1The Scripps Res. Inst., La Jolla, CA, USA; 2Shiley Ctr. for Orthopaedic Res.
and Ed. (SCORE) at Scripps Clinic, La Jolla, CA, USA
Purpose: Cartilage defects resulting from osteoarthritis (OA), aging, and
joint injury are a major cause of joint pain and chronic disability.
Without blood vessels, nerves, and lymphatics in structure, articular
cartilage has difﬁculties to heal spontaneously. The most common
treatment for advanced cartilage damages is joint replacement surgery.
However, it is highly invasive, complicated and expensive. Current
cartilage tissue engineering strategies can yet fabricate new tissue
that is indistinguishable from surrounding cartilage with respect
to zonal organization, extracellular matrix (ECM) composition, and
mechanical properties. The objective of our study is to develop a
high-throughput bio-printing technology to precisely deliver human
chondrocytes and biomaterial scaffold in three dimensions (3D) with
desired cell distribution for direct cartilage repair.
Methods: A Hewlett-Packard Deskjet 500 thermal inkjet printer
was modiﬁed for bio-printing. Isolated human chondrocytes with
oncentration of 5 million cells/mL was printed layer by layer in 20% w/v
poly(ethylene glycol) dimethacrylate (PEGDMA) and 0.05% w/v photo-
initiator. A bovine osteochondral (OC) plug with a full thickness cartilage
